Strategic corporate acquisition

Strategic corporate acquisition is the purchase of a foreign firm or asset to obtain control of technology, infrastructure, market position or data for a strategic purpose. A commercial acquisition becomes an instrument of statecraft only when evidence establishes state direction, financing or another public nexus. Buyer nationality, Chinese ownership or later government intervention does not by itself prove the original acquisition was state-directed.

Mechanism

Acquisition can deliver legal title, governance rights, access to personnel and continuing participation in a target's supply chain. A state may use a state-owned enterprise, policy bank, sovereign fund or directed private vehicle, but the public nexus must be shown through ownership, control, financing, tasking or another documented link. China's military-civil fusion policy can be relevant to risk assessment without proving that every Chinese investor or acquisition is state-directed. Screening regimes therefore assess control, technology, infrastructure, data and transaction-specific risk. They are evidence of the reviewing state's defensive policy, not proof of the buyer's strategic intent.

Control is not confined to majority ownership. Board appointment rights, access to non-public technical information, vetoes over strategic decisions and contractual influence may matter, while a passive financial holding may not deliver operational control. The transaction record must identify the rights actually acquired. State financing can support an inference of public nexus, but concessional credit alone does not establish tasking or the purpose of the acquisition.

Employment history

The United States screens covered transactions through CFIUS. FIRRMA (2018) expanded the committee's jurisdiction, including over specified non-controlling investments involving critical technology, critical infrastructure or sensitive personal data, and strengthened procedural tools. Review can lead to clearance, mitigation, prohibition by the President or divestment, depending on the transaction and national-security risk. The EU now operates under Regulation (EU) 2026/1386 on foreign-investment screening. National and EU screening processes coordinate defensive review; they do not convert every reviewed purchase into a proven statecraft operation. A case entry must therefore identify the buyer, beneficial control, financing, rights acquired, public nexus and strategic purpose separately.

Mitigation can preserve a transaction while limiting access, governance or sensitive operations. A prohibition establishes the reviewing authority's risk judgment under its statute. Neither outcome, without more, proves that the buyer acted for a foreign government.

Effects and countermeasures

Successful acquisitions can transfer legal title, workforce, intellectual property and supply-chain position. Screening may impose mitigation, block a transaction or require divestment, while corporate courts can adjudicate governance separately. The Netherlands' Nexperia episode shows the distinction. The Dutch government invoked the Goods Availability Act on 30 September 2025. It later suspended its ministerial order after consultations. Separate Enterprise Chamber proceedings concerned governance measures, including management and voting control; the government stated that it was not responsible for those court actions. As at 30 July 2026, the government order's suspension and the court track must not be merged into one nationalisation or screening decision. Full treatment sits at Dutch intervention in Nexperia and Chinese export restrictions (2025-present).

See also

Committee on Foreign Investment in the United States (CFIUS) · FIRRMA (2018) · Military-Civil Fusion (Civil-Military Fusion) · Dutch intervention in Nexperia and Chinese export restrictions (2025-present) · Economic statecraft

Sources

• US Treasury, CFIUS laws and guidance, accessed 30 July 2026.
• US Foreign Investment Risk Review Modernization Act 2018, accessed 30 July 2026.
• Regulation (EU) 2026/1386 on foreign-investment screening, accessed 30 July 2026.
• Netherlands Government, Nexperia Goods Availability Act update, accessed 30 July 2026.